The presence of a significant relationship between HSPA-2 expression and important prognostic parameters such as macroscopic tumor size, lymphovascular invasion, pT, pN, pM, TNM stage, and survival rate suggests that HSPA-2 can be used as prognostic marker in LSCC with an immunohistochemical analysis. The gene discussed is HSPA2; the disease is neoplasm.